category guide

How to choose Ultrasound Therapy Equipment

May 1, 2026· 12 min read· AI-generated

How to choose Ultrasound Therapy Equipment

A procurement guide for PT clinics, sports-medicine practices, hospital PM&R departments, and ASC rehab programs evaluating therapeutic ultrasound units.

What this is and who buys it

Therapeutic ultrasound is not the same device that produces a diagnostic image. These units deliver pulsed or continuous high-frequency acoustic energy — typically between 0.8 MHz and 3.0 MHz — through a handheld piezoelectric transducer pressed against coupling gel on the patient's skin. The mechanical energy produces two distinct physiological effects: thermal (deep tissue heating that increases collagen extensibility and local circulation) and non-thermal (acoustic streaming and stable cavitation that are believed to modulate cell-membrane permeability and promote tissue repair). Clinically, the technology is used to manage musculoskeletal pain, muscle spasm, and joint contracture, and is reimbursed under CPT code 97035 when provided by a licensed clinician.

The buyers are predominantly outpatient physical therapy and sports-medicine clinics, chiropractic offices, hospital Physical Medicine and Rehabilitation (PM&R) departments, ambulatory surgery centers with integrated rehab services, and collegiate or professional athletic training rooms. In the outpatient PT world specifically, therapeutic ultrasound units are among the highest-frequency capital purchases after electrotherapy platforms — they wear out, their transducers degrade silently, and clinics opening new treatment rooms need them on day one. The other major purchase trigger is combination-modality expansion: adding simultaneous ultrasound-plus-electrical-stimulation capability to capture incremental billing where clinic workflow supports it.

The technology itself is mature — piezoelectric therapy transducers have existed for decades — but that maturity creates procurement traps. Older units circulate in the used-equipment market long after their acoustic output has drifted out of calibration tolerance, and a significant proportion of in-service units at any given time are delivering incorrect doses without the treating clinician knowing it. That makes purchase decisions and ongoing calibration discipline more consequential than they might appear for a device in the $1,000–$5,000 price range.

Key decision factors

Frequency options and depth of penetration. The frequency you choose determines how deep the acoustic energy travels into tissue. At 1 MHz, the beam penetrates to roughly 3–5 cm, making it appropriate for deep structures like the lumbar paraspinals, hip joint, or quadriceps. At 3 MHz, the energy is absorbed within approximately 1–3 cm of the skin surface, which is better suited for superficial tendons, ligaments, and small joint capsules. For clinical versatility, a dual-frequency transducer head is essentially a baseline requirement on any clinical unit; a device limited to a single frequency will restrict your therapists' protocol options.

Effective Radiating Area and Beam Non-Uniformity Ratio. ERA (in cm²) describes the active acoustic face of a transducer; BNR is the ratio of peak-to-average spatial intensity and determines how evenly energy is distributed across that face. IEC 60601-2-5 sets an upper BNR limit of 8:1 — values above that threshold indicate dangerous intensity spikes that can cause localized tissue damage even at standard intensity settings [S3]. A well-specified clinical transducer should report a BNR of 5:1 or lower and an ERA in the 4.0 ± 1.0 cm² range for a standard 5 cm² head [S5]. Always request these values for each soundhead configuration, measured per IEC 61689.

Output accuracy and calibration tolerance. This is where most procurement decisions underweight the risk. Manufacturers typically calibrate total output power to within ±20% of the digital display reading, which is already a meaningful variance in a clinical setting. Field survey data, however, shows the real-world situation is considerably worse: independent testing has found that roughly 69% of therapeutic ultrasound machines had output power differing from the indicated value by more than 30%, with machines older than 10–12 years and some dual-frequency heads performing particularly poorly [S5]. Buying a unit with a wide factory tolerance, no calibration certificate at delivery, or no clear recalibration pathway is a clinical-liability exposure, not just a procurement inconvenience.

Continuous versus pulsed mode and duty cycle control. Non-thermal effects — the cavitation and streaming mechanisms used for acute inflammation and wound-healing protocols — require pulsed mode at controlled duty cycles, most commonly 10%, 20%, or 50%. A unit that only offers continuous mode, or whose timer accuracy is not independently verified, is unsuitable for the full range of clinical indications. Confirm that duty cycle selection and timer accuracy are included in the factory performance verification.

Soundhead sizes and ergonomic design. A standard 5 cm² head handles the bulk of musculoskeletal work, but a smaller 1–2 cm² head is essential for tendons (Achilles, rotator cuff), small joint capsules, and underwater technique used in hand therapy. Look for pre-calibrated, hot-swappable applicators with a standardized connector, and an auto-pause or contact-quality detection circuit that cuts output when the head lifts off the skin — this is both a safety feature and a unit-of-service integrity measure.

Standalone versus combination platform. Combo units that pair ultrasound with TENS, interferential current (IFC), or neuromuscular electrical stimulation (NMES) on a single chassis save floor space and enable simultaneous CPT 97032/97035 billing in protocols where both modalities are clinically indicated. The tradeoff is that a single chassis failure takes both modalities offline simultaneously, and the ultrasound channel in a combo device must carry its own FDA 510(k) clearance — it cannot borrow the e-stim clearance [S1].

Portability and power requirements. Battery-operated portable units weighing 3–5 kg are appropriate for multi-room clinics, home-visit services, or athletic training environments where clinicians carry equipment between rooms or facilities. Cart-mounted systems belong in fixed high-volume treatment bays. Verify that portable units intended for battery operation can complete a full treatment session (typically 5–10 minutes per area) on a single charge under realistic clinical duty cycles.

What it costs

Pricing in this category is publicly available from distributor catalogs and manufacturer websites, so budget benchmarks are reasonably reliable. The range spans almost an order of magnitude depending on frequency options, portability, and whether you're bundling electrical stimulation.

Entry-level ($300–$900): Basic single-frequency portable units with limited duty-cycle options and no combination modality. Appropriate for low-volume satellite clinics or adjunctive-use settings, but confirm 510(k) clearance and BNR specs before purchase — this price band has the highest concentration of non-compliant imports.
Mid-range ($1,200–$2,500): Dual-frequency portable units with pulsed and continuous modes, auto-pause, and at least two soundhead sizes. Retail pricing for units in this class is publicly listed under $2,000 at major distributors [S7, S8]. This is the segment covering the majority of outpatient PT clinic purchases.
Premium ($3,000–$7,000+): Cart-based ultrasound-plus-multi-channel e-stim combination platforms with EMR connectivity, protocol presets, and multiple applicators. Full configurations with cart, accessory heads, and extended warranty fall in the upper end of this band. Pricing for specific configurations should be confirmed directly with distributors, as accessory bundling significantly affects the final price.

Common use cases

Therapeutic ultrasound is a broad-indication modality, but the clinical contexts that drive the most procurement activity follow recognizable patterns. Matching the unit's specification to the dominant case mix — rather than purchasing for every possible scenario — usually produces better clinical and financial outcomes.

Outpatient orthopedic and sports-medicine PT clinics: High-volume use for tendinopathy (patellar, Achilles, rotator cuff), bursitis, myofascial trigger points, and post-immobilization joint contracture. A dual-frequency unit with both 1 cm² and 5 cm² heads covers the full diagnostic spread.
Chiropractic and manual therapy offices: Adjunctive use for paraspinal muscle spasm and lumbar/cervical joint stiffness before manipulation; 1 MHz continuous mode is the dominant protocol. Single-room practices often need only one portable unit.
Hospital PM&R and inpatient rehabilitation: Post-operative contracture management and scar-tissue remodeling, where pulsed 3 MHz protocols at low intensity are common. EMR integration and patient-data logging are more important in this setting than in private practice.
Athletic training rooms (collegiate/professional): Battery-powered portables that move between treatment tables, sidelines, and training facilities. Durability of the transducer connector and hot-swap capability matter more here than programmability.

Regulatory and compliance

Therapeutic ultrasound units for physical medicine are regulated by FDA as Class II medical devices under 21 CFR 890.5300(a), product codes IMI and PFW, and require 510(k) premarket notification before commercial distribution [S2]. This is not a trivial formality: the 510(k) clearance defines the specific indications for use, and a device used outside its cleared indications creates liability exposure for the facility. Combination ultrasound-plus-electrical-stimulation devices have a more complex regulatory pathway — the ultrasound channel must carry a separate clearance, and combo units marketed for indications beyond deep-heat for pain, spasm, and contracture may require Premarket Approval (PMA) rather than 510(k) [S1]. Verify clearance for the exact configuration you are purchasing by searching the FDA 510(k) database directly using the model name and product code.

From a technical standards perspective, compliant clinical units should conform to IEC 60601-1 (third edition, general electrical safety), IEC 60601-1-2 (fourth edition, EMC), and IEC 60601-2-5 (particular requirements for ultrasonic physiotherapy equipment), with acoustic output measurement conducted per IEC 61689 (0.5–5 MHz performance) [S3, S4]. IEC 60601-2-5 sets the BNR ceiling at 8:1 and caps spatial-average intensity at a level (commonly cited at 3 W/cm² for handheld therapy heads) above which the standard requires additional safety justification. Devices that cannot produce a conformity declaration against these standards should not be considered for clinical use, regardless of price. HIPAA obligations apply only if the unit logs identifiable patient treatment data into a networked EMR — a standalone unit with no connectivity does not trigger HIPAA compliance requirements on its own.

Service, training, and total cost of ownership

Installation for a portable ultrasound unit is essentially plug-and-play, but cart-based combination systems should receive a biomedical engineering incoming inspection on delivery — verify electrical safety (leakage current per IEC 60601-1), acoustic output against the factory calibration certificate, and EMC performance in the intended room environment. Clinical in-service training typically runs one to two hours per staff cohort, and any vendor unable to provide written treatment protocols mapped to ICD-10 diagnoses and CPT 97035 documentation requirements is leaving your therapists to figure out billing compliance on their own.

The calibration story is where therapeutic ultrasound total cost of ownership diverges most sharply from the sticker price. Annual acoustic-output and timer verification — using a radiation-force balance traceable to IEC 61689 — is the de facto biomed standard given the documented field failure rate. If outsourced to the OEM or an ISO 17025-accredited calibration lab, budget approximately $150–$300 per transducer head per year. That cost is small relative to the clinical and liability consequences of delivering incorrect dosing, but it adds up across a multi-head fleet. Transducers are the most failure-prone component: in heavy clinical use, expect replacement at the three-to-five year mark. Generator chassis typically last eight to twelve years before calibration drift and parts availability make recapitalization more economical than continued service. Maintenance contracts on generator platforms run roughly $200–$500 per year, but read the fine print — soundhead replacement is frequently excluded as a "consumable," even though it is the most likely repair item.

Red flags to watch for

A vendor who cannot immediately produce the FDA 510(k) number and product code for the specific unit being sold should be treated as a disqualifying situation, not a follow-up item. Look it up in the FDA database yourself — clearance takes minutes to verify and its absence means the device is legally not authorized for clinical use in the United States [S1, S2].

Any transducer specification that omits published BNR and ERA values, or that lists a BNR above 8:1, is out of IEC 60601-2-5 compliance and presents a burn-risk hazard at standard clinical intensity settings [S3]. Similarly, an output accuracy specification wider than ±20%, or a unit shipped without a factory calibration certificate, indicates the manufacturer is not meeting even the minimum performance documentation standard. Combination units deserve particular scrutiny: some imported combo platforms bundle an FDA-cleared TENS channel with an ultrasound channel that carries no independent 510(k) clearance — the entire product may appear compliant from the outside while the ultrasound component is not. Finally, be skeptical of "lifetime warranty" claims on any unit that excludes the transducer — that exclusion nullifies the warranty's clinical value entirely, since the transducer is almost certainly what will fail first.

Questions to ask vendors

Provide the FDA 510(k) clearance number, product code (IMI or PFW), and the exact indications-for-use statement for this specific configuration — including each soundhead included in the package.
What are the published ERA (cm²) and BNR values for each soundhead at 1 MHz and 3 MHz, measured per IEC 61689, and can you provide the test data?
What is the factory output-accuracy tolerance (±%) in continuous and pulsed modes, and is a traceable calibration certificate shipped with each unit?
What is the recommended recalibration interval, which entity performs it, and what is the per-head cost? Are loaner heads available during the service period?
Provide conformity declarations for IEC 60601-1 (third edition), IEC 60601-1-2 (fourth edition, EMC), and IEC 60601-2-5 — and the underlying test reports from a recognized test lab.
What is the warranty term on the generator chassis versus each soundhead separately, and what is the parts-availability commitment in years following product discontinuation?

Alternatives

The most consequential alternative decision is new versus refurbished. Used therapeutic ultrasound units can reduce acquisition cost by roughly 50% versus new list price, which is meaningful when equipping multiple treatment rooms. The risk is that output degradation in field-aged units is silent — the display may read 1.5 W/cm² while the transducer is delivering half that or twice that — and a refurbished unit without a current (within 12 months) acoustic-output calibration certificate from an accredited lab is essentially an unknown dose device. Given the documented failure rates in machines older than ten to twelve years, avoid units of uncertain vintage regardless of cosmetic condition, and never buy refurbished without that calibration documentation in hand [S5].

Leasing versus purchasing follows a straightforward logic in this category. A single portable unit at $1,000–$2,000 is generally too small a capital item to justify lease administrative overhead; buy it outright. Cart-based combination systems in the $5,000–$7,000 range may make sense on a 36–60 month fair-market-value lease for a new clinic managing cash flow, particularly when the lease is structured to bundle electrotherapy and possibly low-level laser alongside. Whether to invest in in-house calibration capability depends entirely on fleet size: a radiation-force balance suitable for acoustic output verification costs $3,000–$8,000 and requires trained biomedical engineering staff — only cost-effective for institutions running ten or more transducer heads. Smaller operations should contract with the OEM or a third-party ISO 17025-accredited service provider. Finally, before committing to a therapeutic ultrasound purchase during a modality recapitalization, consider whether the clinical case mix actually justifies it: for indications where ultrasound evidence is equivocal — such as chronic nonspecific low back pain — shockwave therapy, pulsed shortwave diathermy, or low-level laser may align better with both the evidence base and your patient population.

Sources

Browse vendors in

Ultrasound Therapy

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.